Cimarron Healthcare Capital

Investor type

PE

Founded

2015

AUM

$447 M

Location

Salt Lake City, Utah, United States

Investment Ticket

$10-50 m

Investment Stage

Series B Late Stage (Series C+)

Region of investment

North America
Investor profile last updated: 16 August, 2026

Profile

Cimarron Healthcare Capital is a private equity firm based in Salt Lake City, Utah, with a specialized focus on the healthcare industry. Founded by experienced investors and operators, the firm has built a team with over 80 years of combined healthcare experience. Cimarron distinguishes itself through a partnership-centric approach, working closely with business owners to transform sub-scale healthcare businesses into high-value platforms poised for growth in the lower-middle market sector.

Cimarron's investment strategy focuses on companies at an inflection point, with the capability of becoming premium platforms. The firm targets equity investments up to $30 million and looks for businesses generating revenue up to $100 million, with up to $10 million in EBITDA. While it focuses primarily on North America, Cimarron is deeply integrated into the healthcare sector and emphasizes building value through significant owner rollovers and a proven track record of growth.

Notable companies in Cimarron's portfolio include AMPS – a healthcare cost management firm, and Elite Anesthesia – a provider of anesthesia services. The firm's purpose-driven pursuit of better healthcare through strategic investments has positioned it as a thought leader in strengthening business models and improving operational efficiency for its portfolio companies.

Industry

Business Services (B2B) Healthcare Services Medical Devices Software Life Sciences HealthTech Financial Services Fintech

Cimarron Healthcare Capital Funds

Name Type
Questionare
Industry
Questionare
Stage
Questionare
Region
Size AUM Launch date
Cimarron Healthcare Capital Fund II, LP
Private Equity (PE)
Business Services (B2B)
Financial Services
Fintech
Healthcare Services
Life Sciences
Series B
Late Stage (Series C+)
North America
$5-10 m
$104 M
November 2021

Contacts

Name
Title
Email
avatar
Jason Vandenakker Managing Partner
Managing Partner
j•••@•••
avatar
Stuart Pace Vice President
Vice President
s•••@•••
Upgrade to see contacts
avatar
6VsGXr1lmHdqR85y 6VsGXr1lmHdqR85y
6VsGXr1lmHdqR85y
avatar
6VsGXr1lmHdqR85y 6VsGXr1lmHdqR85y
6VsGXr1lmHdqR85y
avatar
6VsGXr1lmHdqR85y 6VsGXr1lmHdqR85y
6VsGXr1lmHdqR85y
Investment-team contacts for Cimarron Healthcare Capital — including verified work emails and LinkedIn profiles — are available to Private Equity List subscribers.
Instant access on the web. Plans from $129/month — see pricing.
Contacts sourced from the firm's website and LinkedIn, re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.

FAQs about Cimarron Healthcare Capital

Cimarron Healthcare Capital is a private equity firm. It backs companies at Series B and Late Stage (Series C+), writing tickets of $10-50 m.
Cimarron Healthcare Capital is located in Salt Lake City, Utah, United States.
Cimarron Healthcare Capital was founded in 2015.
Cimarron Healthcare Capital invests in companies and startups in Business Services (B2B), Healthcare Services, Medical Devices, Software, Life Sciences, HealthTech, Financial Services, Fintech.
Cimarron Healthcare Capital invests in companies and startups in North America.
Cimarron Healthcare Capital invests in companies and startups at Series B, Late Stage (Series C+).
Cimarron Healthcare Capital usually invests $10-50 m on average.
Cimarron Healthcare Capital has around $447m assets under management.
Cimarron Healthcare Capital last fund was created/launched in 2021-11-05
Cimarron Healthcare Capital can be reached through its website cimarronhc.com and its LinkedIn page. Its general enquiries address is [email protected]. Cold-mailing a general inbox rarely reaches a partner, so Private Equity List also lists the investment-team contacts for Cimarron Healthcare Capital — names, roles, verified work emails and LinkedIn profiles — available on a Pro plan from $129/month (see pricing). Contacts are sourced from the firm's website and LinkedIn and re-verified on a rolling cycle. Spot a stale contact, or none at all? Report it — we re-run that firm within 48h and get back to you.
Yes. Every field on this page — profile, funds, investment criteria, portfolio and investment-team contacts — is available programmatically through the Private Equity List REST API and MCP server, so AI assistants such as Claude and ChatGPT can query Cimarron Healthcare Capital directly instead of scraping this page. One subscription covers both the web app and machine access — see API & MCP.
Private Equity List re-verifies investor profiles on a rolling cycle, pulling from the firm's own website and LinkedIn rather than a one-off import. This profile was last updated on 16 August, 2026. Something out of date here? Report it — we re-run that firm within 48h and get back to you.